$TPCS
TECHPRECISION CORP

2023 Q2 Form 10-K Financial Statement

#000141057823001442 Filed on June 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2023
Revenue $7.371M $7.505M $31.43M
YoY Change 4.17% -0.74% 41.06%
Cost Of Revenue $6.677M $6.657M $26.53M
YoY Change 6.68% 3.59% 40.32%
Gross Profit $694.1K $847.9K $4.904M
YoY Change -15.06% -25.3% 45.23%
Gross Profit Margin 9.42% 11.3% 15.6%
Selling, General & Admin $1.274M $1.582M $6.009M
YoY Change -7.36% -8.44% 30.12%
% of Gross Profit 183.53% 186.58% 122.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $559.7K $550.7K $2.217M
YoY Change -4.38% 14.28% 51.84%
% of Gross Profit 80.64% 64.95% 45.22%
Operating Expenses $1.274M $1.582M $6.009M
YoY Change -7.36% -8.44% 30.12%
Operating Profit -$579.8K -$734.1K -$1.105M
YoY Change 3.91% 23.84% -10.98%
Interest Expense $94.09K -$94.63K $355.6K
YoY Change 12.48% 7.68% -232.01%
% of Operating Profit
Other Income/Expense, Net -$94.09K $12.77K $321.8K
YoY Change -19.5% -130.56% -1233.49%
Pretax Income -$673.9K -$816.0K -$783.4K
YoY Change -0.15% 102.75% 44.49%
Income Tax -$146.4K $186.8K $195.6K
% Of Pretax Income
Net Earnings -$527.5K -$1.003M -$979.0K
YoY Change 5.25% 68.3% 179.85%
Net Earnings / Revenue -7.16% -13.36% -3.11%
Basic Earnings Per Share -$0.06 -$0.11
Diluted Earnings Per Share -$0.06 -$0.12 -$0.11
COMMON SHARES
Basic Shares Outstanding 8.613M 34.44M 8.596M
Diluted Shares Outstanding 8.613M 8.596M

Balance Sheet

Concept 2023 Q2 2023 Q1 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $271.9K $534.5K $534.5K
YoY Change -52.6% -49.2% -49.2%
Cash & Equivalents $271.9K $534.5K $534.5K
Short-Term Investments
Other Short-Term Assets $324.5K $349.0K $349.0K
YoY Change -55.44% -75.45% -75.45%
Inventory $2.452M $2.413M $2.413M
Prepaid Expenses
Receivables $2.966M $2.336M $11.28M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.67M $14.58M $14.58M
YoY Change -5.45% -9.26% -9.26%
LONG-TERM ASSETS
Property, Plant & Equipment $15.38M $13.91M $19.57M
YoY Change 18.87% -28.78% 0.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $121.3K $121.3K $2.052M
YoY Change -82.17% -94.61% -8.7%
Total Long-Term Assets $23.07M $21.63M $21.63M
YoY Change 4.21% -0.72% -0.72%
TOTAL ASSETS
Total Short-Term Assets $14.67M $14.58M $14.58M
Total Long-Term Assets $23.07M $21.63M $21.63M
Total Assets $37.73M $36.21M $36.21M
YoY Change 0.23% -4.35% -4.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $743.9K $2.224M $2.224M
YoY Change -80.96% -35.09% -35.09%
Accrued Expenses $2.552M $2.533M $2.886M
YoY Change -26.19% -8.02% 4.78%
Deferred Revenue $2.854M $2.334M
YoY Change 59.75% 32.19%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.865M $1.218M $1.218M
YoY Change -7.09% -70.24% -70.24%
Total Short-Term Liabilities $9.731M $9.021M $9.021M
YoY Change -24.36% -32.25% -32.25%
LONG-TERM LIABILITIES
Long-Term Debt $4.603M $4.749M $4.749M
YoY Change 53.95% 52.46% 52.46%
Other Long-Term Liabilities $4.370M $2.699M $7.843M
YoY Change 236.14% -56.17% 27.35%
Total Long-Term Liabilities $8.973M $7.449M $12.59M
YoY Change 109.16% -19.68% 35.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.731M $9.021M $9.021M
Total Long-Term Liabilities $8.973M $7.449M $12.59M
Total Liabilities $23.67M $21.61M $21.61M
YoY Change 3.65% -4.32% -4.32%
SHAREHOLDERS EQUITY
Retained Earnings -$883.9K -$356.4K
YoY Change -828.07% -157.25%
Common Stock $861.00 $861.00
YoY Change -74.9% -74.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.07M $14.59M $14.59M
YoY Change
Total Liabilities & Shareholders Equity $37.73M $36.21M $36.21M
YoY Change 0.23% -4.35% -4.35%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2023
OPERATING ACTIVITIES
Net Income -$527.5K -$1.003M -$979.0K
YoY Change 5.25% 68.3% 179.85%
Depreciation, Depletion And Amortization $559.7K $550.7K $2.217M
YoY Change -4.38% 14.28% 51.84%
Cash From Operating Activities $115.1K $2.267M $3.138M
YoY Change -92.06% 18.91% 1116.97%
INVESTING ACTIVITIES
Capital Expenditures $1.854M $1.057M $2.325M
YoY Change 808.91% -310.37% -347.64%
Acquisitions
YoY Change
Other Investing Activities $0.00 $7.000K
YoY Change -100.09%
Cash From Investing Activities -$1.854M -$1.057M -$2.318M
YoY Change 142.99% 110.37% -73.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $147.4K $605.9K
YoY Change -4.35% 52.43%
Cash From Financing Activities 1.476M -991.6K -1.337M
YoY Change -226.81% 8.45% -118.07%
NET CHANGE
Cash From Operating Activities 115.1K 2.267M 3.138M
Cash From Investing Activities -1.854M -1.057M -2.318M
Cash From Financing Activities 1.476M -991.6K -1.337M
Net Change In Cash -262.6K 218.3K -517.7K
YoY Change -45.13% -55.42% -52.0%
FREE CASH FLOW
Cash From Operating Activities $115.1K $2.267M $3.138M
Capital Expenditures $1.854M $1.057M $2.325M
Free Cash Flow -$1.739M $1.210M $812.5K
YoY Change -239.7% -49.77% -32.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
5853791
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2699492
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
305071
CY2023Q1 tpcs Number Of Series Of Preferred Stock Shares
NumberOfSeriesOfPreferredStockShares
1
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.37
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
3804625
CY2023Q1 tpcs Advances To Employee
AdvancesToEmployee
4561
CY2022Q1 tpcs Advances To Employee
AdvancesToEmployee
9668
CY2023Q1 tpcs Prepaid Advisory Fees Other
PrepaidAdvisoryFeesOther
30455
CY2022Q1 tpcs Prepaid Advisory Fees Other
PrepaidAdvisoryFeesOther
20160
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
348983
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1421459
CY2022Q1 tpcs Accrued Contingent Consideration Current
AccruedContingentConsiderationCurrent
63436
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
235014
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
147590
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2533185
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3435866
CY2022Q1 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
800000
CY2023Q1 us-gaap Liabilities
Liabilities
21613590
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8595992
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8095058
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8595992
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8095058
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
9941848
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
155754
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
35000
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
46256
CY2022 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2269000
CY2022 tpcs Stock Issued During Period Value Private Placement Net
StockIssuedDuringPeriodValuePrivatePlacementNet
3187582
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-349834
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-21838
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3523000
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001328792
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 tpcs Business Acquisitions Proforma Weighted Average Shares Outstanding Diluted
BusinessAcquisitionsProformaWeightedAverageSharesOutstandingDiluted
8558739
CY2022 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://www.tech.pre.com/20230331#GainLossFromContingentConsideration
CY2023 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://www.tech.pre.com/20230331#GainLossFromContingentConsideration
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8613408
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8576862
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-979006
CY2023Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.25
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-51378
CY2023 dei Entity Registrant Name
EntityRegistrantName
TechPrecision Corporation
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
51-0539828
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1 Bella Drive
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Westminster
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01473
CY2023 dei City Area Code
CityAreaCode
978
CY2023 dei Local Phone Number
LocalPhoneNumber
874-0591
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2023 dei Trading Symbol
TradingSymbol
TPCS
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
43800000
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8613408
CY2023 dei Auditor Firm
AuditorFirmId
688
CY2023 dei Auditor Name
AuditorName
Marcum LLP
CY2023 dei Auditor Location
AuditorLocation
Philadelphia, Pennsylvania
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
534474
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1052139
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2336481
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3009249
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
8947811
CY2022Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
8350231
CY2023Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1692852
CY2022Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
874538
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
719736
CY2022Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1360137
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
348983
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1421459
CY2023Q1 us-gaap Assets Current
AssetsCurrent
14580337
CY2022Q1 us-gaap Assets Current
AssetsCurrent
16067753
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13914024
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13153165
CY2023Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
5660938
CY2022Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
6383615
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1931186
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2126770
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
121256
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
121256
CY2023Q1 us-gaap Assets
Assets
36207741
CY2022Q1 us-gaap Assets
Assets
37852559
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2224320
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3426921
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2533185
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3435866
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2333591
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1765319
CY2023Q1 tpcs Lease Liability Current
LeaseLiabilityCurrent
711727
CY2022Q1 tpcs Lease Liability Current
LeaseLiabilityCurrent
593808
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1218162
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
4093079
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9020985
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
13314993
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4749139
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3114936
CY2023Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
5143974
CY2022Q1 us-gaap Liabilities
Liabilities
22588791
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8613408
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8576862
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
861
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
858
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14949729
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14640343
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-356439
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
622567
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
14594151
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
15263768
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36207741
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37852559
CY2023 us-gaap Revenues
Revenues
31431614
CY2022 us-gaap Revenues
Revenues
22282495
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
26527953
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18905938
CY2023 us-gaap Gross Profit
GrossProfit
4903661
CY2022 us-gaap Gross Profit
GrossProfit
3376557
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6008881
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4938086
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-1105220
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1561529
CY2023 tpcs Other Income And Expense
OtherIncomeAndExpense
40842
CY2022 tpcs Other Income And Expense
OtherIncomeAndExpense
-28385
CY2023 us-gaap Interest Expense
InterestExpense
355608
CY2022 us-gaap Interest Expense
InterestExpense
269375
CY2023 tpcs Employee Retention Credit Refund
EmployeeRetentionCreditRefund
636564
CY2022 tpcs Paycheck Protection Program Loan Forgiveness
PaycheckProtectionProgramLoanForgiveness
1317100
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
321798
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1019340
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-783422
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-542189
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
195584
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-192355
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-979006
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-349834
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-1909
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-19929
CY2022 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-21838
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-979006
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-371672
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
15263768
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
109079
CY2023 tpcs Stock Issued During Period Value Contingent Consideration
StockIssuedDuringPeriodValueContingentConsideration
56310
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
144000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-979006
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
14594151
CY2023 us-gaap Profit Loss
ProfitLoss
-979006
CY2022 us-gaap Profit Loss
ProfitLoss
-349834
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2217472
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1460439
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
59916
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
48251
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
468
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
253079
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
190754
CY2023 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
237318
CY2022 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
223111
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
195584
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-192355
CY2022 tpcs Employee Retention Credit Refunds And Paycheck Protection Program Loan Forgiveness
EmployeeRetentionCreditRefundsAndPaycheckProtectionProgramLoanForgiveness
1317100
CY2023 tpcs Stock Based Expense For Contingent Consideration
StockBasedExpenseForContingentConsideration
56310
CY2023 tpcs Gain Loss From Contingent Consideration
GainLossFromContingentConsideration
63436
CY2022 tpcs Gain Loss From Contingent Consideration
GainLossFromContingentConsideration
-50454
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-672768
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
842943
CY2023 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
597580
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-1012783
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
177914
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
42491
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1072476
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-354993
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2394420
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-50633
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1202601
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
245743
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1094137
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1477552
CY2023 tpcs Increase Decrease In Contract Liabilities
IncreaseDecreaseInContractLiabilities
568273
CY2022 tpcs Increase Decrease In Contract Liabilities
IncreaseDecreaseInContractLiabilities
1390441
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3137838
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
257839
CY2022 tpcs Business Acquisition Net Of Cash Acquired
BusinessAcquisitionNetOfCashAcquired
7795810
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2325301
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
939004
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2318301
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8734814
CY2022 tpcs Proceeds From Term Loan
ProceedsFromTermLoan
4000000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
335418
CY2023 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10885150
CY2022 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
4612002
CY2023 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
11522152
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
3325000
CY2023 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
57723
CY2022 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
169884
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
36572
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
508806
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
605905
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
397490
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1337202
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7398404
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-517665
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1078571
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1052139
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2130711
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
534474
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1052139
CY2023 us-gaap Interest Paid Net
InterestPaidNet
288085
CY2022 us-gaap Interest Paid Net
InterestPaidNet
236575
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 1 - DESCRIPTION OF BUSINESS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">TechPrecision Corporation, or “TechPrecision”, is a Delaware corporation organized in February 2005 under the name Lounsberry Holdings II, Inc. On February 24, 2006, we acquired all the issued and outstanding capital stock of our wholly owned subsidiary Ranor, Inc., or “Ranor.” Ranor, together with its predecessors, has been in continuous operation since 1956. The name was changed to TechPrecision Corporation on March 6, 2006.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">TechPrecision is the parent company of Ranor, Westminster Credit Holdings, LLC, or “WCH”, Stadco New Acquisition, LLC, or “Acquisition Sub”, Stadco and Wuxi Critical Mechanical Components Co., Ltd., or “WCMC”, a wholly foreign owned enterprise. WCMC was dissolved and deregistered in November 2021. TechPrecision, Ranor, WCH, WCMC (until November 2021), Acquisition Sub and Stadco are collectively referred to as the “Company”, “we”, “us” or “our”. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On August 25, 2021, the Company completed its acquisition of Stadco, pursuant to that certain stock purchase agreement with Acquisition Sub, Stadco Acquisition, LLC, Stadco and each equity holder of Stadco Acquisition, LLC. On the closing date, the Company, through Acquisition Sub, acquired all the issued and outstanding capital stock of Stadco from Stadco Acquisition, LLC in exchange for the issuance of shares of the Company’s common stock to Stadco Acquisition, LLC. As a result of the acquisition, Stadco is now our wholly owned indirect subsidiary. See Note 3 for additional disclosures related to this business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">We manufacture large-scale metal fabricated and machined precision components and equipment. These products are used in a variety of markets including defense and aerospace, nuclear, medical, and precision industrial. All our operations and customers are in the United States, or “U.S.”.</p>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Use of Estimates in the Preparation of Financial Statements -</i> In preparing the consolidated financial statements in conformity with generally accepted accounting principles in the United States, or “U.S. GAAP”, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and revenues and expenses during the reported period. We continually evaluate our estimates, including those related to revenue recognition, long-lived assets, and income taxes. We base our estimates on historical and current experiences and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ from those estimates.</p>
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-349834
CY2023Q1 tpcs Maximum Spending Limit On Machinery And Equipment
MaximumSpendingLimitOnMachineryAndEquipment
1500000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
22000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Measurement Input
BusinessCombinationContingentConsiderationLiabilityMeasurementInput
50.0
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
63436
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2022 tpcs Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Initial Measurement At Fair Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityInitialMeasurementAtFairValue
113890
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-50454
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
63436
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-63436
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2022 tpcs Other Adjustment To Credit Liability
OtherAdjustmentToCreditLiability
135249
CY2022 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
320000
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2823979
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2484723
CY2023 us-gaap Professional Fees
ProfessionalFees
1795904
CY2022 us-gaap Professional Fees
ProfessionalFees
1630151
CY2023 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1388998
CY2022 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
823212
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6008881
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4938086
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
253079
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
190754
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax
19929
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25000
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.72
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
46256
CY2023 tpcs Business Acquisitions Proforma Net Sales
BusinessAcquisitionsProformaNetSales
27002535
CY2023 tpcs Business Acquisitions Proforma Operating Income Loss
BusinessAcquisitionsProformaOperatingIncomeLoss
-2937391
CY2023 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
-2151614
CY2023 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-1393987
CY2023 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.16
CY2023 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.16
CY2023 tpcs Business Acquisitions Proforma Weighted Average Share Outstanding Basic
BusinessAcquisitionsProformaWeightedAverageShareOutstandingBasic
8558739
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31431614
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
22282495
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31431614
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
22282495
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
44000000.0
CY2023Q1 tpcs Revenue Remaining Performance Obligation Completed Less Than50
RevenueRemainingPerformanceObligationCompletedLessThan50
37700000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.50
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1800000
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
8947811
CY2022Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
8350231
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.355
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-783422
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-542189
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
195584
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-192355
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-979006
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-349834
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-261372
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-567459
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
456956
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
375104
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
195584
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-192355
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
195584
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-192355
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-164519
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-113860
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-151878
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-70130
CY2022 tpcs Nontaxable Ppp Loan Forgiveness
NontaxablePppLoanForgiveness
-339022
CY2023 tpcs Nondeductible Items Related To Dissolved Foreign Entity
NondeductibleItemsRelatedToDissolvedForeignEntity
65482
CY2022 tpcs Nondeductible Items Related To Dissolved Foreign Entity
NondeductibleItemsRelatedToDissolvedForeignEntity
294232
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
239622
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
227037
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
216485
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-173004
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-20983
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-4620
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
11375
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-12988
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
195584
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-192355
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.250
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5839915
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6099169
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
213308
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
191976
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
242579
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
234752
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
126792
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
322463
CY2023Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6422594
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6848360
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2170094
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1953609
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4252500
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4894751
CY2023Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1971644
CY2022Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2259094
CY2023Q1 tpcs Deferred Tax Liabilities Contract Accounting Methods
DeferredTaxLiabilitiesContractAccountingMethods
349670
CY2022Q1 tpcs Deferred Tax Liabilities Contract Accounting Methods
DeferredTaxLiabilitiesContractAccountingMethods
508887
CY2023Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2321314
CY2022Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2767981
CY2023Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1931186
CY2022Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2126770
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2200000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8613408
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8576862
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-979006
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-349834
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8595992
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8095058
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-979006
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-349834
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8595992
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8095058
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
679750
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.49
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3597700
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M13D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
12250
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
667500
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.37
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3597700
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y7M28D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
667500
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.37
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3804625
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y8M12D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
667500
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y8M12D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
667500
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.37
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3804625
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y8M12D
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0
CY2023Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
667500
CY2023Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
667500
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
34000
CY2021Q4 tpcs Stock Issued Shares For Finder Fee
StockIssuedSharesForFinderFee
5000
CY2021Q4 tpcs Stock Issued For Finder Fee
StockIssuedForFinderFee
35000
CY2023Q1 us-gaap Prepaid Taxes
PrepaidTaxes
9616
CY2022Q1 us-gaap Prepaid Taxes
PrepaidTaxes
26497
CY2022Q1 tpcs Erc Refundable Credits
ErcRefundableCredits
1093661
CY2023Q1 us-gaap Prepaid Insurance
PrepaidInsurance
162075
CY2022Q1 us-gaap Prepaid Insurance
PrepaidInsurance
184275
CY2023Q1 tpcs Prepaid Subscriptions
PrepaidSubscriptions
120570
CY2022Q1 tpcs Prepaid Subscriptions
PrepaidSubscriptions
66098
CY2023Q1 tpcs Deposits Current
DepositsCurrent
21706
CY2022Q1 tpcs Deposits Current
DepositsCurrent
21100
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
26572388
CY2022Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
24260166
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
12658364
CY2022Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
11107001
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
13914024
CY2022Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
13153165
CY2023 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
14297
CY2022 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1257245
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
947938
CY2023Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
256227
CY2022Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
935382
CY2023Q1 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
102954
CY2022Q1 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
340272
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
241195
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
513379
CY2023Q1 tpcs Accrued Project Costs
AccruedProjectCosts
440550
CY2022Q1 tpcs Accrued Project Costs
AccruedProjectCosts
487869
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6113013
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
7355920
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
145712
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
147905
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
5967301
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
7208015
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1218162
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
4093079
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4749139
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3114936
CY2023Q1 tpcs Late Charge Fee Percentage
LateChargeFeePercentage
5
CY2023Q1 tpcs Default Interest Rate
DefaultInterestRate
5
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1250200
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
625791
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
651827
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
678980
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
2636854
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
269361
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
6113013
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1000000.0
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
300000
CY2023Q1 tpcs Aggregate Delinquent And Unpaid Outstanding Amounts For Water Water Service Electric Energy And Or Electric Service Current
AggregateDelinquentAndUnpaidOutstandingAmountsForWaterWaterServiceElectricEnergyAndOrElectricServiceCurrent
200000
CY2023Q1 tpcs Aggregate Delinquent And Unpaid Outstanding Amounts For Water Water Service Electric Energy And Or Electric Service Noncurrent
AggregateDelinquentAndUnpaidOutstandingAmountsForWaterWaterServiceElectricEnergyAndOrElectricServiceNoncurrent
1500000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
638732
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
363206
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
20829
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
27955
CY2023 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1536
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1851
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y3M
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y3M
CY2023Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y9M
CY2022Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y5M23D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045
CY2023Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.045
CY2022Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.039
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
851806
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
448206
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
36572
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
508806
CY2023Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
957495
CY2023Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
948701
CY2023Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
948702
CY2023Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
938801
CY2023Q1 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
938802
CY2023Q1 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
2111578
CY2023Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
6844079
CY2023Q1 tpcs Finance Lease Liability Imputed Interest
FinanceLeaseLiabilityImputedInterest
-988378
CY2023Q1 tpcs Finance Lease Liabilities
FinanceLeaseLiabilities
5855701
CY2023Q1 tpcs Employee Agreement Annual Commitment For Future Salaries During Next Fiscal Year
EmployeeAgreementAnnualCommitmentForFutureSalariesDuringNextFiscalYear
600000
CY2023Q1 tpcs Employee Agreement Annual Commitment For Vacation And Holiday
EmployeeAgreementAnnualCommitmentForVacationAndHoliday
1000000.0
CY2023Q1 us-gaap Purchase Obligation
PurchaseObligation
5700000
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
84889
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
89316
CY2021Q2 us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
495000
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31431614
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22282495
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-1105220
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1561529
CY2023 us-gaap Interest Expense Other
InterestExpenseOther
314766
CY2022 us-gaap Interest Expense Other
InterestExpenseOther
297761
CY2023 tpcs Employee Retention Credit Refund
EmployeeRetentionCreditRefund
636564
CY2022 tpcs Paycheck Protection Program Loan Forgiveness
PaycheckProtectionProgramLoanForgiveness
1317100
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-783422
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-542189
CY2023Q1 us-gaap Assets
Assets
36207741
CY2022Q1 us-gaap Assets
Assets
37852559
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2217472
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1460439
CY2023 tpcs Capital Expenditures From Purchase Of Fixed Assets
CapitalExpendituresFromPurchaseOfFixedAssets
2325301
CY2022 tpcs Capital Expenditures From Purchase Of Fixed Assets
CapitalExpendituresFromPurchaseOfFixedAssets
939004

Files In Submission

Name View Source Status
0001410578-23-001442-index-headers.html Edgar Link pending
0001410578-23-001442-index.html Edgar Link pending
0001410578-23-001442.txt Edgar Link pending
0001410578-23-001442-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpcs-20230331.xsd Edgar Link pending
tpcs-20230331x10k.htm Edgar Link pending
tpcs-20230331xex21d1.htm Edgar Link pending
tpcs-20230331xex23d1.htm Edgar Link pending
tpcs-20230331xex31d1.htm Edgar Link pending
tpcs-20230331xex31d2.htm Edgar Link pending
tpcs-20230331xex32d1.htm Edgar Link pending
tpcs-20230331_cal.xml Edgar Link unprocessable
tpcs-20230331_def.xml Edgar Link unprocessable
tpcs-20230331_pre.xml Edgar Link unprocessable
tpcs-20230331_lab.xml Edgar Link unprocessable
tpcs-20230331x10k_htm.xml Edgar Link completed